Need Assistance?
  • US & Canada:
    +
  • UK: +

BQ-123

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

BQ-123 is a selective endothelin A receptor (ETA) antagonist with IC50 of 7.3 nM. Phase 2.

Category
Peptide Inhibitors
Catalog number
BAT-010810
CAS number
136553-81-6
Molecular Formula
C31H42N6O7
Molecular Weight
610.70
BQ-123
IUPAC Name
2-[(3R,6R,9S,12R,15S)-6-(1H-indol-3-ylmethyl)-9-(2-methylpropyl)-2,5,8,11,14-pentaoxo-12-propan-2-yl-1,4,7,10,13-pentazabicyclo[13.3.0]octadecan-3-yl]acetic acid
Synonyms
BQ123; BQ-123; BQ 123. Cyclo(D-trp-D-asp-pro-D-val-leu).
Appearance
Lyophilized Powder
Purity
98%
Density
1.33±0.1 g/cm3(Predicted)
Boiling Point
1053.6±65.0°C(Predicted)
Sequence
cyclo[D-Asp-Pro-D-Val-Leu-D-Trp]
Storage
Store at -20°C
Solubility
Soluble in DMSO (100 mg/mL), Ethanol (15 mg/mL)
InChI
InChI=1S/C31H42N6O7/c1-16(2)12-21-27(40)33-22(13-18-15-32-20-9-6-5-8-19(18)20)28(41)35-23(14-25(38)39)31(44)37-11-7-10-24(37)29(42)36-26(17(3)4)30(43)34-21/h5-6,8-9,15-17,21-24,26,32H,7,10-14H2,1-4H3,(H,33,40)(H,34,43)(H,35,41)(H,36,42)(H,38,39)/t21-,22+,23+,24-,26+/m0/s1
InChI Key
VYCMAAOURFJIHD-PJNXIOHISA-N
Canonical SMILES
CC(C)CC1C(=O)NC(C(=O)NC(C(=O)N2CCCC2C(=O)NC(C(=O)N1)C(C)C)CC(=O)O)CC3=CNC4=CC=CC=C43
1.Developmental conversion of inotropism by endothelin I and angiotensin II from positive to negative in mice.
Sekine T1, Kusano H, Nishimaru K, Tanaka Y, Tanaka H, Shigenobu K. Eur J Pharmacol. 1999 Jun 25;374(3):411-5.
Inotropic effects on isolated neonatal and adult mouse myocardium of endothelin I and angiotensin II were examined. Endothelin I produced a sustained positive inotropic response in the neonate but a sustained negative response in the adult. Both were concentration-dependent and were inhibited by the endothelin ETA receptor antagonist, BQ-123 (Cyclo(D-a-aspartyl-L-prolyl-D-valyl-L-leucyl-D-tryptophyl)). Angiotensin II produced a sustained positive inotropic response in the neonate while a sustained negative response in the adult. Both were concentration-dependent and were inhibited by the angiotensin AT1 receptor antagonist, YM358 (2,7-diethyl-5-((2'-(1 H-tetrazol-5-yl)biphenyl-4-yl)methyl-5H-pyrazolo(1,5-b)(1,2,4)tria zole potassium salt monohydrate). These results indicate that inotropic responses of the mouse heart to cardioactive peptides are unique among experimental animal species and may be reversed during development.
Online Inquiry
Verification code
Inquiry Basket